首页 > 资料专栏 > 地区 > 其他国家 > 亚洲 > IBEF_印度医疗行业分析(英文)_2018.10_35页

IBEF_印度医疗行业分析(英文)_2018.10_35页

惠慷医疗
V 实名认证
内容提供者
热门搜索
资料大小:3204KB(压缩后)
文档格式:WinRAR
资料语言:中文版/英文版/日文版
解压密码:m448
更新时间:2019/8/3(发布于浙江)
阅读:1
类型:积分资料
积分:25分 (VIP无积分限制)
推荐:升级会员

   点此下载 ==>> 点击下载文档


文本描述
.Table of Content Executive Summary.……..….3Advantage India…..….……...4Market Overview and Trends….......6Notable Strategies and Trends Adopted...11Growth Drivers..........15Opportunities…….…….…..27Key Industry Organisations..……......…….30Useful information.…32For updated information, please visitHealthcare 3 EXECUTIVE SUMMARYSource: Business Standard, Ministry of External Affairs, Ministry of External Affairs (Investment and Technology Promotion Division), ASSOCHAM-RNCOS joint paper, Lancet studyIndia is expected to rank amongst the top three healthcare markets in terms of incremental growth by 2020.In FY17, Indian healthcare sector stood as the fourth largest employer as the sector employed a total of319,780 people. The sector is expected to generate 40 million jobs in India by 2020. In May 2017, the Asian Research and Training Institute for Skill Transfer (ARTIST) announced plans tocreate around one million skilled healthcare providers by 2022.100,000 jobs are expected to be created from Ayushman Bharat, the National Health Protection Scheme.Fourth Largest EmployerIndian healthcare sector, is expected to record a threefold rise, at a CAGR of 22 per cent during 2016-2022to reach US$ 372 billion in 2022 from US$ 110 billion in 2016.India ranks 145th among 195 countries in terms of quality and accessibility of healthcare. There is immensescope for enhancing healthcare services penetration in India, thus presenting ample opportunity fordevelopment of the healthcare industry.Impressive GrowthProspectsRising income levels, ageing population, growing health awareness and changing attitude towards preventivehealthcare is expected to boost healthcare services demand in future.The low cost of medical services has resulted in a rise in the country’s medical tourism, attracting patientsfrom across the world. Moreover, India has emerged as a hub for R&D activities for international players dueto its relatively low cost of clinical research.Strong Fundamentals andCost AdvantageConducive policies for encouraging FDI, tax benefits, favourable government policies coupled with promisinggrowth prospects have helped the industry attract private equity, venture capitals and foreign players.Favourable InvestmentEnvironment HEALTHCAREADVANTAGE INDIA。。。。。。